ZA200608496B - Compressed pharmaceutical compositions comprising PEG and electrolytes - Google Patents
Compressed pharmaceutical compositions comprising PEG and electrolytes Download PDFInfo
- Publication number
- ZA200608496B ZA200608496B ZA200608496A ZA200608496A ZA200608496B ZA 200608496 B ZA200608496 B ZA 200608496B ZA 200608496 A ZA200608496 A ZA 200608496A ZA 200608496 A ZA200608496 A ZA 200608496A ZA 200608496 B ZA200608496 B ZA 200608496B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical composition
- peg
- composition
- polyethylene glycol
- compressed pharmaceutical
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 30
- 239000003792 electrolyte Substances 0.000 title claims abstract description 17
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 95
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 88
- 239000000203 mixture Substances 0.000 claims abstract description 63
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 26
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 25
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 24
- 210000001072 colon Anatomy 0.000 claims description 21
- 206010010774 Constipation Diseases 0.000 claims description 17
- 238000011282 treatment Methods 0.000 claims description 17
- 239000000796 flavoring agent Substances 0.000 claims description 14
- 239000001103 potassium chloride Substances 0.000 claims description 13
- 235000011164 potassium chloride Nutrition 0.000 claims description 13
- 235000002639 sodium chloride Nutrition 0.000 claims description 13
- 239000011780 sodium chloride Substances 0.000 claims description 12
- 206010056325 Faecaloma Diseases 0.000 claims description 11
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 11
- 235000011152 sodium sulphate Nutrition 0.000 claims description 11
- 235000003599 food sweetener Nutrition 0.000 claims description 10
- 239000003765 sweetening agent Substances 0.000 claims description 10
- 230000014759 maintenance of location Effects 0.000 claims description 7
- 235000013355 food flavoring agent Nutrition 0.000 claims description 6
- 230000000968 intestinal effect Effects 0.000 claims description 6
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 6
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 5
- 206010016766 flatulence Diseases 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 230000002746 orthostatic effect Effects 0.000 claims description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 235000010323 ascorbic acid Nutrition 0.000 claims description 2
- 239000011668 ascorbic acid Substances 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- 125000003289 ascorbyl group Chemical class [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 claims description 2
- 239000000843 powder Substances 0.000 abstract description 8
- 239000007788 liquid Substances 0.000 abstract description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 16
- 239000000243 solution Substances 0.000 description 14
- 239000008141 laxative Substances 0.000 description 11
- 238000009472 formulation Methods 0.000 description 8
- 235000017557 sodium bicarbonate Nutrition 0.000 description 8
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 230000002475 laxative effect Effects 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 6
- 229920002562 Polyethylene Glycol 3350 Polymers 0.000 description 5
- 229940125722 laxative agent Drugs 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 229940056944 golytely Drugs 0.000 description 4
- 230000003204 osmotic effect Effects 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 210000000664 rectum Anatomy 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 241000792859 Enema Species 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 2
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 229940096516 dextrates Drugs 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 239000007920 enema Substances 0.000 description 2
- 229960003511 macrogol Drugs 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- WSWCOQWTEOXDQX-MQQKCMAXSA-M (E,E)-sorbate Chemical compound C\C=C\C=C\C([O-])=O WSWCOQWTEOXDQX-MQQKCMAXSA-M 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 239000001329 FEMA 3811 Substances 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940001468 citrate Drugs 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 238000002052 colonoscopy Methods 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 210000004921 distal colon Anatomy 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 229940095399 enema Drugs 0.000 description 1
- 229940079360 enema for constipation Drugs 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229940050411 fumarate Drugs 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- -1 granular Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000002597 lactoses Chemical class 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 description 1
- 229940089953 neohesperidin dihydrochalcone Drugs 0.000 description 1
- 235000010434 neohesperidine DC Nutrition 0.000 description 1
- 239000007968 orange flavor Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940075554 sorbate Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0409104.7A GB0409104D0 (en) | 2004-04-23 | 2004-04-23 | Compressed pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200608496B true ZA200608496B (en) | 2008-07-30 |
Family
ID=32344298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200608496A ZA200608496B (en) | 2004-04-23 | 2006-10-11 | Compressed pharmaceutical compositions comprising PEG and electrolytes |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20070298100A1 (de) |
| EP (2) | EP1742645B1 (de) |
| JP (1) | JP2007533719A (de) |
| KR (1) | KR20070001280A (de) |
| CN (1) | CN1950097A (de) |
| AT (1) | ATE496626T1 (de) |
| AU (1) | AU2005235345B8 (de) |
| BR (1) | BRPI0510175A (de) |
| CA (1) | CA2561649C (de) |
| DE (1) | DE602005026117D1 (de) |
| DK (2) | DK2263680T3 (de) |
| ES (2) | ES2519540T3 (de) |
| GB (1) | GB0409104D0 (de) |
| IL (1) | IL178722A0 (de) |
| MX (1) | MXPA06011906A (de) |
| NO (1) | NO20064780L (de) |
| PL (2) | PL2263680T3 (de) |
| PT (2) | PT2263680E (de) |
| RU (1) | RU2006137347A (de) |
| SI (2) | SI2263680T1 (de) |
| WO (1) | WO2005102364A1 (de) |
| ZA (1) | ZA200608496B (de) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2607250C (en) * | 2005-05-06 | 2012-11-06 | Salix Pharmaceuticals, Inc. | Polyethylene glycol colonic purgative composition |
| ES2278537B1 (es) * | 2006-01-30 | 2008-09-16 | Laboratorios Casen-Fleet, S.L. | Procedimiento de fabricacion de una solucion a base de polietilenglicol con electrolitos, producto obtenido y uso. |
| US20090130048A1 (en) * | 2007-11-19 | 2009-05-21 | Oronsky Bryan Todd | Topical Composition for Treating Pain |
| US8784872B2 (en) * | 2007-11-19 | 2014-07-22 | Comgenrx, Inc. | Formulation for decreasing tobacco, alcohol, drug or food consumption |
| PL2304146T3 (pl) | 2008-06-06 | 2014-07-31 | Roto Frank Ag | Urządzenie uruchamiające dla okna, drzwi lub tym podobnych |
| US20100104614A1 (en) * | 2008-06-27 | 2010-04-29 | Oronsky Bryan T | Providone compositions for wound healing |
| AU2010239378B2 (en) | 2009-04-21 | 2013-11-21 | Dark Canyon Laboratories, Llc | Colon lavage system |
| EP2657243A1 (de) * | 2009-06-03 | 2013-10-30 | Aptalis Pharma Canada, Inc. | L-Zucker-Darmreinigungsmittel und Verwendungen davon |
| GB0913295D0 (en) * | 2009-07-30 | 2009-09-02 | Norgine Bv | Improvements in and relating to pharmaceutical compositions |
| BR112012013679A8 (pt) * | 2009-12-07 | 2016-09-06 | Aptalis Pharma Canada Inc | Método de separação de uma impureza iônica de uma corrente de processo contendo monossacarídeos, método de separação de uma impureza iônica de uma corrente de processo contendo sacarídeos, método contínuo de separação de impurezas catiônicas e aniônicas de uma corrente de processo contendo l-monossacarídeos, l-glicose possuindo uma pureza de pelo menos 98%, composição farmacêutica e método para preparo do cólon |
| CN101766648B (zh) * | 2010-03-02 | 2012-01-11 | 舒泰神（北京）生物制药股份有限公司 | 聚乙二醇电解质颗粒制剂及其制造方法 |
| DE202010012256U1 (de) * | 2010-09-07 | 2010-11-11 | Krewel Meuselbach Gmbh | Abführmittel |
| MX342181B (es) * | 2010-11-04 | 2016-09-20 | Norgine Bv | Formulaciones que comprenden polietilenglicol. |
| FI9608U1 (fi) * | 2010-11-04 | 2012-03-29 | Norgine Bv | Formulaatiot |
| AU2011100528B4 (en) * | 2011-05-10 | 2011-08-25 | Norgine Bv | Formulations |
| DE202010016235U1 (de) | 2010-12-06 | 2011-05-19 | Norgine B.V. | Formulierungen |
| CN103391790B (zh) | 2011-01-28 | 2016-06-15 | 布伦特里实验室有限公司 | 用于肠道清洁的方法、组合物以及包装 |
| DK2862566T3 (da) * | 2011-01-31 | 2022-05-16 | Norgine Healthcare B V | Forbedringer i og relateret til sammensætninger |
| TWI535461B (zh) | 2011-03-11 | 2016-06-01 | 諾金私人有限公司 | 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法 |
| CN102133225B (zh) * | 2011-03-18 | 2012-11-21 | 海南锦瑞制药股份有限公司 | 一种复方聚乙二醇电解质散剂及其制备方法 |
| CA2853520C (en) * | 2011-10-27 | 2021-11-16 | Thomas Julius Borody | Electrolyte purgatives |
| CN102600201B (zh) * | 2012-02-07 | 2014-07-16 | 舒泰神（北京）生物制药股份有限公司 | 用于通便和清肠的药物组合物及其制备方法 |
| CN105007915B (zh) | 2012-09-11 | 2018-09-28 | 诺金股份有限公司 | 包含peg和抗坏血酸的组合物 |
| JP6441890B2 (ja) * | 2013-03-15 | 2018-12-19 | ブレインツリー・ラボラトリーズ，インコーポレイテッド | 硫酸塩の両用経口薬学的組成物錠剤およびその使用の方法 |
| US10350165B2 (en) | 2014-12-12 | 2019-07-16 | Ojai Energetics Pbc | Methods and systems for forming stable droplets |
| NZ732700A (en) * | 2014-12-12 | 2024-07-05 | Ojai Energetics Pbc | Microencapsulated cannabinoid compositions |
| FR3056109B1 (fr) * | 2016-09-21 | 2019-10-11 | Pierre Fabre Medicament | Utilisation de formulations solides de polyethylene glycol dans le traitement de la constipation |
| CN107028876B (zh) * | 2016-10-09 | 2020-09-29 | 舒泰神（北京）生物制药股份有限公司 | 聚乙二醇电解质口服液及其制备方法 |
| CN110945063B (zh) | 2017-07-20 | 2022-08-16 | 索尔维公司 | 作为发泡剂的官能化的微粒碳酸氢盐、含有其的可发泡聚合物组合物及其在制造热塑性发泡聚合物中的用途 |
| KR20190093489A (ko) | 2018-02-01 | 2019-08-09 | 주식회사태준제약 | 장세척 조성물 |
| WO2019151829A1 (ko) * | 2018-02-01 | 2019-08-08 | 주식회사태준제약 | 장세척 조성물 |
| CN110433174A (zh) * | 2019-07-17 | 2019-11-12 | 华南理工大学 | 一种高依从性的复方聚乙二醇电解质散剂及其制备方法与应用 |
| CN111617102B (zh) * | 2020-05-25 | 2022-05-31 | 南京金凯木纳米材料有限公司 | 一种含聚乙二醇的电解质散剂及其制备方法 |
| CA3199266A1 (en) * | 2020-10-26 | 2022-05-05 | Braintree Laboratories, Inc. | Sulfate salt formulations for colon cleansing |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3121663A (en) * | 1956-02-09 | 1964-02-18 | Plough Lab Inc | Carbon dioxide releasing laxative suppository |
| US5229132A (en) * | 1985-02-22 | 1993-07-20 | Grimberg Georges Serge | Non-absorbable gastrointestinal medicament provided for treating the two levels of the digestive tract at the same time |
| AU6196786A (en) * | 1985-08-01 | 1987-03-05 | Braintree Laboratories Inc. | Low-sodium laxative and lavage formulation |
| US5273758A (en) * | 1991-03-18 | 1993-12-28 | Sandoz Ltd. | Directly compressible polyethylene oxide vehicle for preparing therapeutic dosage forms |
| US6121663A (en) * | 1997-05-22 | 2000-09-19 | Advanced Micro Devices, Inc. | Local interconnects for improved alignment tolerance and size reduction |
| FR2784897B1 (fr) * | 1998-10-27 | 2002-11-29 | Agronomique Inst Nat Rech | Utilisation d'un laxatif osmotique non fermente dans le traitement et la prevention des cancers colorectaux |
| US6444198B1 (en) * | 1999-02-22 | 2002-09-03 | Smithkline Beecham Corporation | Effervescent laxatives |
| DE19933148A1 (de) * | 1999-07-20 | 2001-01-25 | Boehringer Ingelheim Int | Ambroxolhaltige Lutschtablette |
| EP1684772A1 (de) * | 2003-11-17 | 2006-08-02 | Braintree Laboratories, Inc. | Therapeutisches peg-lösungskonzentrat |
| US7687075B2 (en) * | 2003-11-19 | 2010-03-30 | Salix Pharmaceuticals, Ltd. | Colonic purgative composition with soluble binding agent |
-
2004
- 2004-04-23 GB GBGB0409104.7A patent/GB0409104D0/en not_active Ceased
-
2005
- 2005-04-25 BR BRPI0510175-1A patent/BRPI0510175A/pt not_active IP Right Cessation
- 2005-04-25 DE DE602005026117T patent/DE602005026117D1/de active Active
- 2005-04-25 WO PCT/GB2005/001555 patent/WO2005102364A1/en active Application Filing
- 2005-04-25 KR KR1020067024419A patent/KR20070001280A/ko not_active Application Discontinuation
- 2005-04-25 AT AT05735983T patent/ATE496626T1/de active
- 2005-04-25 EP EP05735983A patent/EP1742645B1/de active Active
- 2005-04-25 CN CNA2005800127497A patent/CN1950097A/zh active Pending
- 2005-04-25 PT PT101770071T patent/PT2263680E/pt unknown
- 2005-04-25 ES ES10177007.1T patent/ES2519540T3/es active Active
- 2005-04-25 DK DK10177007.1T patent/DK2263680T3/en active
- 2005-04-25 DK DK05735983.8T patent/DK1742645T3/da active
- 2005-04-25 PL PL10177007T patent/PL2263680T3/pl unknown
- 2005-04-25 JP JP2007508973A patent/JP2007533719A/ja active Pending
- 2005-04-25 PL PL05735983T patent/PL1742645T3/pl unknown
- 2005-04-25 SI SI200531914T patent/SI2263680T1/sl unknown
- 2005-04-25 ES ES05735983T patent/ES2361816T3/es active Active
- 2005-04-25 PT PT05735983T patent/PT1742645E/pt unknown
- 2005-04-25 US US11/587,114 patent/US20070298100A1/en not_active Abandoned
- 2005-04-25 CA CA2561649A patent/CA2561649C/en not_active Expired - Fee Related
- 2005-04-25 EP EP10177007.1A patent/EP2263680B1/de active Active
- 2005-04-25 AU AU2005235345A patent/AU2005235345B8/en not_active Ceased
- 2005-04-25 MX MXPA06011906A patent/MXPA06011906A/es active IP Right Grant
- 2005-04-25 SI SI200531271T patent/SI1742645T1/sl unknown
- 2005-04-25 RU RU2006137347/15A patent/RU2006137347A/ru unknown
-
2006
- 2006-10-11 ZA ZA200608496A patent/ZA200608496B/en unknown
- 2006-10-18 NO NO20064780A patent/NO20064780L/no not_active Application Discontinuation
- 2006-10-18 IL IL178722A patent/IL178722A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20064780L (no) | 2007-01-18 |
| RU2006137347A (ru) | 2008-05-27 |
| PT1742645E (pt) | 2011-04-29 |
| IL178722A0 (en) | 2007-02-11 |
| DK2263680T3 (en) | 2014-12-08 |
| PT2263680E (pt) | 2014-11-19 |
| US20070298100A1 (en) | 2007-12-27 |
| CA2561649C (en) | 2014-10-14 |
| AU2005235345B2 (en) | 2011-04-14 |
| EP2263680A1 (de) | 2010-12-22 |
| SI1742645T1 (sl) | 2011-05-31 |
| ES2361816T3 (es) | 2011-06-22 |
| CA2561649A1 (en) | 2005-11-03 |
| AU2005235345A1 (en) | 2005-11-03 |
| EP1742645B1 (de) | 2011-01-26 |
| SI2263680T1 (sl) | 2015-01-30 |
| ATE496626T1 (de) | 2011-02-15 |
| WO2005102364A1 (en) | 2005-11-03 |
| MXPA06011906A (es) | 2007-01-25 |
| GB0409104D0 (en) | 2004-05-26 |
| PL1742645T3 (pl) | 2011-06-30 |
| PL2263680T3 (pl) | 2015-02-27 |
| KR20070001280A (ko) | 2007-01-03 |
| DK1742645T3 (da) | 2011-05-09 |
| EP1742645A1 (de) | 2007-01-17 |
| BRPI0510175A (pt) | 2007-10-02 |
| CN1950097A (zh) | 2007-04-18 |
| ES2519540T3 (es) | 2014-11-07 |
| AU2005235345B8 (en) | 2011-05-12 |
| JP2007533719A (ja) | 2007-11-22 |
| DE602005026117D1 (de) | 2011-03-10 |
| EP2263680B1 (de) | 2014-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2263680B1 (de) | Peg und elektrolyten enthaltene komprimierte arzneimittelzusammensetzungen | |
| EP1567193B1 (de) | Darmreinigungsmittel zusammensetzungen | |
| MXPA06010295A (es) | Composiciones farmaceuticas comprimidas que contienen peg y electrolitos. | |
| US6444198B1 (en) | Effervescent laxatives | |
| US20130189377A1 (en) | Compositions | |
| EP2322190B1 (de) | Zusammensetzung zur Darmreinigung und deren Verwendung | |
| CA2362355A1 (en) | Effervescent laxatives | |
| Schiller | Colon preparation: Is less more? | |
| US20160271120A1 (en) | Pharmaceutical composition for cleansing of the gastrointestinal tract | |
| MXPA01008492A (en) | Effervescent laxatives |